Healthcare
Econ Healthcare profit soars 96.3% YoY in H1
Econ Healthcare profit soars 96.3% YoY in H1
Interim dividend stood at 0.48 cents per ordinary share.
Hyphens Pharma's Q3 net profit falls to $2m
Meanwhile, revenue rose thanks to stronger sales in Singapore and Malaysia.
MSE proposes new bill to safeguard food security
It aims to consolidate and update existing food-related legislation.
Cordlife Group directors waive fees for FY2024 amidst shareholder inquiries
The move comes after shareholder inquiries ahead of an extraordinary general meeting.
SG to mandate all private hospitals to share patient data with NEHR
Patients can opt out of having their essential medical data shared.
Six in 10 S’poreans at higher risk for developing diabetes complications
90% identified food as the most impactful factor on glucose levels.
Livingstone Health forecasts H1 2025 profit on revenue growth
In H1 2024, the company recorded a $3m loss.
AstraZeneca’s new cancer drug manufacturing facility to create 800 jobs in Singapore
The facility is set to be operational by 2029.
Parliament urges proactive support for seniors through Age Well SG
Around 100,000 seniors are expected to face mild disability by 2030.
What lies ahead for Singapore’s medical device market?
The sector will benefit from rising healthcare expenditure driven by an ageing population.
IHH Healthcare acquires Penang's Island Hospital for $1.2b
The group now operates 18 hospitals across Malaysia.
SG to launch national strategy for allied health professionals
It will also implement a mandatory continuing professional education by 2026.
Singapore adds $13.2m to pandemic fund
This brings the city-state’s total contribution to $26.4m (US$20m).
Tianjin Pharma posts 11 % net profit rise in Q3 2024
The group’s Chinese medicine segment primarily drove revenue, which contributed $807.8m.
SAM Holdings widens net loss in FY24 on higher finance costs
Loss per share was at $0.0480.
Cordlife to hold EGM on 14 Nov to pass resolutions
It proposes to pay directors' fees of up to $135,000 for 2024.
Healthway Medical launches new foot care services for diabetics
The team will use a multidisciplinary approach.
Commentary
Singapore’s family offices: Time to professionalise or risk falling behind
Liquidity crucial to stock market reform